What Makes Intuitive Surgical (ISRG) a Hedge Against Market Risk?
Key takeaways
- What Makes Intuitive Surgical (ISRG) a Hedge Against Market Risk?
- In its first-quarter 2026 investor letter, Grow Funds highlighted stocks like Intuitive Surgical, Inc.
- Grow Funds stated the following regarding Intuitive Surgical, Inc.
What Makes Intuitive Surgical (ISRG) a Hedge Against Market Risk? Soumya Eswaran Tue, June 23, 2026 at 6:53 PM GMT+7 2 min read ISRG ^RUT Grow Funds, an investment Advisor, released its Q1 2026 investor letter for “GROW Small Cap Equity Long/Short Fund”. A copy of the letter can be downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index’s –2.80%, HFRI Equity Hedge Index’s -0.24%, and the HFRI Fundamental Growth Index’s 0.47% returns. Long positions and hedges, and short positions, safeguarded the portfolio amid the volatility driven by the Iran War. In addition, please check the Strategy’s top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Grow Funds highlighted stocks like Intuitive Surgical, Inc. (NASDAQ:ISRG). Intuitive Surgical, Inc. (NASDAQ:ISRG) is a leader in robotic-assisted surgery that develops, manufactures, and markets products for improving the quality of and access to minimally invasive care. On June 22, 2026, Intuitive Surgical, Inc. (NASDAQ:ISRG) closed at $402.95 per share. One-month return of Intuitive Surgical, Inc. (NASDAQ:ISRG) was -7.72%, and its shares lost 22.97% over the past 52 weeks. Intuitive Surgical, Inc. (NASDAQ:ISRG) has a market capitalization of $142.71 billion.
Grow Funds stated the following regarding Intuitive Surgical, Inc. (NASDAQ:ISRG) in its Q1 2026 investor letter: